What is the history of Legg-Calvé-Perthes disease?

Legg-Calvé-Perthes disease was independently and simultaneously identified in 1910 by three physicians—Arthur Legg, Jacques Calvé, and Georg Perthes—who recognized it as a distinct form of hip osteonecrosis rather than tuberculosis. Since its discovery, medical understanding has shifted from viewing Legg-Calvé-Perthes disease as a simple inflammatory process to recognizing it as a complex, multifactorial disruption of blood supply to the femoral head that requires careful, long-term orthopedic management.

How was Legg-Calvé-Perthes disease first identified?

Before 1910, children presenting with hip pain and a limp were almost universally diagnosed with "hip tuberculosis," which was the prevailing medical consensus of the era. However, Arthur Legg (USA), Jacques Calvé (France), and Georg Perthes (Germany) published independent reports within months of each other describing a non-infectious, self-limiting condition of the femoral head. By using early X-ray technology, these pioneers proved that the femoral head was undergoing necrosis and subsequent revascularization, effectively separating Legg-Calvé-Perthes disease from the stigmatized and devastating diagnosis of bone tuberculosis.

How has our understanding of Legg-Calvé-Perthes disease evolved?

For decades, the medical community struggled to identify the precise etiology of Legg-Calvé-Perthes disease. Early 20th-century theories often blamed endocrine imbalances or minor trauma. As orthopedics advanced, researchers shifted their focus toward vascular compromise. Today, we understand that this condition is likely multifactorial, involving a combination of inherited coagulation disorders, environmental factors, and temporary disruptions in the blood supply to the epiphysis of the hip. Modern imaging, including high-resolution MRI, has allowed clinicians to stage the disease more accurately than the original 1910 X-ray methods allowed.

What were the major milestones in treating Legg-Calvé-Perthes disease?

Treatment history reflects the evolution of orthopedic philosophy, moving from aggressive, long-term immobilization to modern approaches prioritizing joint mobility. Key historical shifts include:

• Early Era (1910-1940s): Prolonged bed rest and traction were the gold standards, often keeping children out of school for years.


• Mid-Century Era (1950s-1970s): The introduction of "containment" philosophy, where braces (like the Scottish Rite orthosis) were used to keep the femoral head within the hip socket.


• Modern Era (1980s-Present): A focus on "hip preservation" surgery (osteotomies) for severe cases and physical therapy to maintain range of motion, balancing the need for containment with the patient’s quality of life.

How have technology and patient advocacy changed the landscape?

The rise of digital patient networks has been transformative. At DiseaseMaps.org, 227 people with Legg-Calvé-Perthes disease have come together to share their personal experiences, providing a collective history that traditional textbooks often miss. Furthermore, modern genetic research has begun to investigate links between Legg-Calvé-Perthes disease and thrombophilia (blood-clotting tendencies), suggesting that some children may have a genetic predisposition to the vascular events that trigger the disease. This shift toward personalized medicine offers hope for earlier intervention and better long-term outcomes for those affected by Legg-Calvé-Perthes disease.

Next steps

• Consult a pediatric orthopedic surgeon specializing in hip preservation to discuss the latest imaging and containment strategies.


• Connect with the community at DiseaseMaps.org to share experiences and learn from others who have navigated the diagnosis.


• Monitor for symptoms such as a persistent limp or knee pain, which is often a referred symptom of hip issues in children.


• Ask your physician about the latest clinical trials regarding blood flow optimization and bone healing.

Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Legg-Calvé-Perthes disease overview.


• Orphanet: Rare disease database entry for Legg-Calvé-Perthes disease (ORPHA:2912).


• OMIM (Online Mendelian Inheritance in Man): Clinical data regarding the genetics of Perthes disease.


• International Perthes Study Group: Research and clinical literature on modern management.